Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 12 | $2.49 | $2.65 | $2.58 |
| Q2 2025 | 12 | $2.60 | $2.81 | $2.68 |
| Q3 2025 | 13 | $2.64 | $2.83 | $2.76 |
| Q4 2025 | 12 | $2.51 | $2.57 | $2.53 |
| Q1 2026 | 7 | $2.72 | $2.79 | $2.76 |
| Q2 2026 | 2 | $2.84 | $2.95 | $2.91 |
| Q3 2026 | 2 | $2.90 | $3.01 | $2.97 |
| Q4 2026 | 2 | $2.75 | $2.85 | $2.81 |
| Q1 2027 | 2 | $2.82 | $2.92 | $2.88 |
| Q2 2027 | 2 | $3.06 | $3.17 | $3.12 |
| Q3 2027 | 5 | $3.11 | $3.23 | $3.18 |
| Q4 2027 | 4 | $3.08 | $3.19 | $3.14 |
Johnson & Johnson last posted its earnings results on Tuesday, October 14th, 2025. The company reported $2.8 earnings per share for the quarter, topping analysts' consensus estimates of $2.76 by $0.04. The company had revenue of 23.99 B for the quarter and had revenue of 88.82 B for the year. Johnson & Johnson has generated $6 earnings per share over the last year ($5.79 diluted earnings per share) and currently has a price-to-earnings ratio of 19.72. Johnson & Johnson has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, October 14th, 2025 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/22/2025 | Q3 2025 | N/A | $2.12 | N/A | $23.76 B | $23.99 B |
| 07/24/2025 | Q2 2025 | N/A | $2.29 | N/A | N/A | $23.74 B |
| 04/23/2025 | Q1 2025 | N/A | $4.57 | N/A | N/A | $21.89 B |
| 02/13/2025 | Q4 2024 | N/A | $1.43 | N/A | N/A | $22.52 B |
| 10/23/2024 | Q3 2024 | N/A | $1.12 | N/A | N/A | $22.47 B |
| 07/25/2024 | Q2 2024 | N/A | $1.95 | N/A | N/A | $22.45 B |
| 05/01/2024 | Q1 2024 | N/A | $1.35 | N/A | N/A | $21.38 B |
| 02/16/2024 | Q4 2023 | N/A | $1.68 | N/A | N/A | $21.40 B |
| 10/27/2023 | Q3 2023 | N/A | $10.32 | N/A | N/A | $21.35 B |
| 07/31/2023 | Q2 2023 | N/A | $1.98 | N/A | N/A | $21.52 B |
| 04/28/2023 | Q1 2023 | N/A | -$0.03 | N/A | N/A | $20.89 B |
| 02/16/2023 | Q4 2022 | N/A | $1.35 | N/A | N/A | $23.71 B |
| 10/27/2022 | Q3 2022 | N/A | $1.70 | N/A | N/A | $20.00 B |
| 07/29/2022 | Q2 2022 | N/A | $1.83 | N/A | N/A | $24.02 B |
| 04/29/2022 | Q1 2022 | N/A | $1.96 | N/A | N/A | $23.43 B |
| 02/17/2022 | Q4 2021 | N/A | $1.80 | N/A | N/A | $24.80 B |
| 10/29/2021 | Q3 2021 | N/A | $1.39 | N/A | N/A | $23.34 B |
| 07/29/2021 | Q2 2021 | N/A | $2.38 | N/A | N/A | $23.31 B |
| 04/30/2021 | Q1 2021 | N/A | $2.35 | N/A | N/A | $22.32 B |
| 02/22/2021 | Q4 2020 | N/A | $0.66 | N/A | N/A | $22.48 B |
Johnson & Johnson has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, October 14th, 2025 based offlast year's report dates.
In the previous quarter, Johnson & Johnson (:JNJ) reported $2.8 earnings per share (EPS) to beat the analysts' consensus estimate of $2.76 by $0.04.
The conference call for Johnson & Johnson's latest earnings report can be listened to online.
The conference call transcript for Johnson & Johnson's latest earnings report can be read online.
Johnson & Johnson (:JNJ) has a recorded annual revenue of $88.82 B.
Johnson & Johnson (:JNJ) has a recorded net income of $14.07 B.Johnson & Johnson has generated $5.84 earnings per share over the last four quarters.
Johnson & Johnson (:JNJ) has a price-to-earnings ratio of 19.72 and price/earnings-to-growth ratio is 1.86.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED